Clinical Trial Update: Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

A combined Irreversible Electroporation and NK immunotherapy trial for recurrent liver carcinoma has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Drugs mentioned

• Irreversible Electroporation
• Natural killer (NK) immunotherapy

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Recurrent Liver Carcinoma | Phase 1, Phase 2 | Status: COMPLETED